Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Milella

Showing results (91-100 of 130) with videos related to

Pageof 13
Sort By:
American Journal of Clinical Oncology|April 25, 2000
Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients: a phase II studyV Ferraresi, M Milella, A Vaccaro, et al.
Journal of Viral Hepatitis|September 13, 2012
SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective studyE Fransvea, P Trerotoli, R Sacco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2020
Reshaping preoperative treatment of pancreatic cancer in the era of precision medicineR Casolino, C Braconi, G Malleo, et al.
Cell Death & Disease|August 7, 2015
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancerG Sette, V Salvati, M Mottolese, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 19, 2007
Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancerE Bria, P Visca, F Novelli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 24, 2011
Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-αC Scagnolari, S Trombetti, A Soldà, et al.
Gastroenterology|July 27, 1999
Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral HepatitisS W Schalm, O Weiland, B E Hansen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancerS Di Cosimo, A Alimonti, G Ferretti, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 20, 2020
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal AdenocarcinomaN Simoni, R Micera, S Paiella, et al.
Leukemia|September 19, 2008
Targeting the leukemic stem cell: the Holy Grail of leukemia therapyN Misaghian, G Ligresti, L S Steelman, et al.
Pageof 13

Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
American Journal of Clinical Oncology|April 25, 2000
Toxicity and activity of docetaxel in anthracycline-pretreated breast cancer patients: a phase II studyV Ferraresi, M Milella, A Vaccaro, et al.
Journal of Viral Hepatitis|September 13, 2012
SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective studyE Fransvea, P Trerotoli, R Sacco, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 28, 2020
Reshaping preoperative treatment of pancreatic cancer in the era of precision medicineR Casolino, C Braconi, G Malleo, et al.
Cell Death & Disease|August 7, 2015
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancerG Sette, V Salvati, M Mottolese, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 19, 2007
Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancerE Bria, P Visca, F Novelli, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 24, 2011
Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-αC Scagnolari, S Trombetti, A Soldà, et al.
Gastroenterology|July 27, 1999
Interferon-ribavirin for chronic hepatitis C with and without cirrhosis: analysis of individual patient data of six controlled trials. Eurohep Study Group for Viral HepatitisS W Schalm, O Weiland, B E Hansen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 19, 2004
Incidence of chemotherapy-induced amenorrhea depending on the timing of treatment by menstrual cycle phase in women with early breast cancerS Di Cosimo, A Alimonti, G Ferretti, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 20, 2020
Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal AdenocarcinomaN Simoni, R Micera, S Paiella, et al.
Leukemia|September 19, 2008
Targeting the leukemic stem cell: the Holy Grail of leukemia therapyN Misaghian, G Ligresti, L S Steelman, et al.
Pageof 13